An increased presence of the complement-inhibitory proteins CD55 and CD59 has been observed in non-small cell lung cancer (NSCLC) among various other malignancies, which has been associated with signaling from cytokines [25]. The gene discussed is CD59; the disease is non-small cell lung carcinoma.